Clinical Trial

Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate the safety and efficacy of conversion therapy using HFRT combined with ICT in locally advanced or metastatic unresectable GEJA.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-09.
Status change: Not Yet Recruiting → Recruiting 2025-11-23
Trial Details
NCT Number NCT07072351
Lead Sponsor West China Hospital
Conditions Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy, Immunotherapy, Chemotherapy
Enrollment 88 participants
Start Date 2025-09-15
Primary Completion 2028-05-14 (estimated)
Study Completion 2028-05-14 (estimated)
Updated on ClinicalTrials.gov 2025-11-28